Terminal
Stocks
Spotlight
Research

Stocks
Healthcare
NASDAQ
MYGN

Market Cap: $323.01M

MI

Myriad Genetics, Inc.

MYGN

NASDAQUSD

Overview News Analyst Reports Financials Politician Trades Insider Trades Executive Patents Earnings Surprise

By Cashu Finance. Providing market news, analysis, and research for investors worldwide.

Company

Stocks About Advertisers Brokers Contact

Legal

Terms of Service Privacy Policy

© 2026 Cashu Technologies Pty Ltd. All rights reserved. Cashu Finance is a trademark of Cashu Technologies Pty Ltd.

The content published on Cashu Finance is for informational purposes only and should not be construed as investment advice, a recommendation, or an offer to buy or sell any securities. All opinions expressed are those of the authors and do not reflect the official position of Cashu Technologies Pty Ltd or its affiliates. Past performance is not indicative of future results. Investing involves risk, including the possible loss of principal. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions.

Cashu Finance and its contributors may hold positions in securities mentioned in published content. Any such holdings will be disclosed at the time of publication. Market data is provided on an "as-is" basis and may be delayed. Cashu Technologies Pty Ltd does not guarantee the accuracy, completeness, or timeliness of any information presented.

Financials

Profitability

Gross Profit Margin68.83%

EBITDA Margin-5.60%

EBIT Margin-11.83%

Pre-tax Margin-13.86%

Net Profit Margin-13.96%

Earnings Yield-34.73%

Valuation Multiples

Price / Book1.07

Price / Sales0.40

Price / Earnings-2.86

PEG-0.04

Forward PEG0.13

EV / Sales0.52

EV / EBITDA-9.25

EV / Operating Cash Flow54.33

EV / Free Cash Flow-48.64

Price / Free Cash Flow-37.56

Price / Operating Cash Flow42.11

Cash Flow & Capital

Free Cash Flow / Share-$0.09

Operating Cash Flow / Share$0.08

Free Cash Flow Yield-2.66%

Capex / Revenue2.02%

Capex / Operating Cash Flow2.12%

Capex / Depreciation0.32

Stock Compensation / Revenue3.56%

Dividend Payout Ratio0.00%

Dividend Yield0.00%

Liquidity & Leverage

Current Ratio2.21

Quick Ratio1.98

Cash Ratio0.88

Debt / Assets0.33

Debt / Capital0.41

Debt / Equity0.69

Long-Term Debt / Capital0.28

Debt / Market Cap39.63%

Net Debt / EBITDA-2.11

Solvency Ratio-0.19

Financial Leverage2.10

Efficiency & Working Capital

Asset Turnover1.26

Fixed Asset Turnover5.08

Inventory Turnover8.22

Receivables Turnover7.37

Payables Turnover8.27

Days Sales Outstanding49.55

Days Inventory Outstanding44.43

Days Payables Outstanding44.14

Operating Cycle93.98

Cash Conversion Cycle49.84

Working Capital Turnover4.73

Returns & Quality

Return on Equity-32.59%

Return on Assets-17.62%

Return on Invested Capital-19.13%

ROCE-19.40%

Return on Tangible Assets-24.87%

Operating Return on Assets-15.02%

Income Quality-0.07

Tax Burden1.01

Interest Burden1.17

Balance Sheet & Intrinsic Metrics

Enterprise Value$418.31M

Invested Capital$503.3M

Working Capital$158.3M

Tangible Asset Value$117.8M

Net Current Asset Value$-46M

Graham Net-Net-$1.29

Book Value / Share$3.21

Tangible Book Value / Share$1.24

Cash / Share$1.22

Financial Health Scores

Piotroski Score4

Altman Z-Score-1.02

Revenue$806.6M

EBIT$-95.4M

Market Cap$300.82M

Working Capital$158.3M

Retained Earnings$-1.2B

Total Assets$638.9M

Total Liabilities$335M